• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to investors navigation
Insmed

Insmed

Powered by Purpose

LinkedIn Twitter Contact Us Job Opportunities

  • Culture
    • Our Culture
      • Mission & Vision
      • Careers
      • Responsibility
        • Inclusion at Insmed
        • Grants & Funding
        • Global Healthcare Compliance

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients
    • Our Patients
      • Disease Areas
        • NTM Lung Disease
        • Bronchiectasis
        • Pulmonary Arterial Hypertension
      • Resources
      • Patient Access

    Current Clinical Trials

    You may be eligible for one of our clinical trials.

    See if you may qualify

  • Science
    • Our Science
      • ARIKAYCE®
      • Our Programs
      • Pipeline
      • Clinical Trials
      • Our Research Team
      • Investigator-Initiated Research

    Our Research Team

    Working together to develop new medicines and technologies that have the potential to transform patients’ lives.

    Learn More

  • About
    • About Insmed
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs
Home / Investors/ News Releases

News Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • Apr 14, 2004
    Insmed Acquires Manufacturing Facility from Baxter International
  • Mar 23, 2004
    Insmed to Present at Wells Fargo Securities Healthcare Conference
  • Mar 23, 2004
    Insmed to Present at Wells Fargo Securities Healthcare Conference; Presentation to Be Webcast Live
  • Feb 11, 2004
    Insmed Incorporated Reports Improved Financial Results for Fourth Quarter 2003 and Twelve-Months Ended December 31, 2003
  • Feb 4, 2004
    Insmed Inc. to Webcast Fourth Quarter Earnings Conference Call; Wednesday, February 11, at 11:00 a.m. ET - 10:00 a.m. CT
  • Jan 26, 2004
    Insmed Obtains Patent Rights for Extreme Insulin Resistance From Fujisawa
  • Dec 15, 2003
    Insmed Receives FDA Orphan Drug Designation For rhIGF-I/rhIGFBP-3, SomatoKine, for Extreme Insulin Resistance
  • Dec 3, 2003
    Insmed Presents Positive Data on Anti-Cancer Drug Candidate to San Antonio Breast Cancer Symposium
  • Dec 2, 2003
    rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes
    rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes
  • Nov 17, 2003
    Insmed Presents Positive Data on Anti-Cancer Drug Candidate to AACR-NCI-EORTC
  • Nov 5, 2003
    Insmed to Present Cancer Data to CaP Cure, the Prostate Cancer Foundation
  • Nov 5, 2003
    Insmed Incorporated Reports Financial Results for Third Quarter 2003 and Nine-Months Ended September 30, 2003
  • Oct 28, 2003
    Insmed Incorporated to Webcast Third Quarter Earnings Conference Call; Wednesday, November 5, at 11:00 a.m. ET - 10:00 a.m. CT
  • Oct 16, 2003
    Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live
    Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live
  • Sep 23, 2003
    Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer
    Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer
  • Sep 15, 2003
    Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology
    Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology
  • Sep 5, 2003
    Company Profile for Insmed Incorporated
    Company Profile for Insmed Incorporated
  • Jul 31, 2003
    Insmed Incorporated Reports Improved Financial Results for Second Quarter and First Half of 2003
    Insmed Incorporated Reports Improved Financial Results for Second Quarter and First Half of 2003
  • Jul 24, 2003
    Insmed Incorporated to Webcast Second Quarter Earnings Conference Call; Thursday, July 31, at 11:00 a.m. ET - 10:00 a.m. CT
    Insmed Incorporated to Webcast Second Quarter Earnings Conference Call; Thursday, July 31, at 11:00 a.m. ET - 10:00 a.m. CT
  • Jul 16, 2003
    Insmed Inc. Conludes Private Placement Led by Wells Fargo Securities Raising $1.9 Million More Than Previously Reported
    Insmed Inc. Conludes Private Placement Led by Wells Fargo Securities Raising $1.9 Million More Than Previously Reported
  • Jul 14, 2003
    Insmed Reports Positive Data to AACR with rhIGFBP-3 in Cancer
    Insmed Reports Positive Data to AACR with rhIGFBP-3 in Cancer
  • Jul 11, 2003
    Insmed Inc. Raises $12 Million in Private Placement of Common Stock Lead by Wells Fargo Securities
    Insmed Inc. Raises $12 Million in Private Placement of Common Stock Lead by Wells Fargo Securities
  • Jul 9, 2003
    Insmed Incorporated to Present Positive Oncology Data On rhIGFBP-3 at the Annual Meeting of the American Association of Cancer Research
    Insmed Incorporated to Present Positive Oncology Data On rhIGFBP-3 at the Annual Meeting of the American Association of Cancer Research
  • Jun 23, 2003
    Insmed Launches Pivotal Phase III Clinical Trial in GHIS; Data Analysis Planned for Early 2004
    Insmed Launches Pivotal Phase III Clinical Trial in GHIS; Data Analysis Planned for Early 2004
  • Jun 20, 2003
    Insmed Presents Positive Data on Lead Drug Candidate at Endocrine Society Annual Meeting; Study Shows Advantages of Company's rhIGF-I/rhIGFBP-3 In Treating Growth Disorder
    Insmed Presents Positive Data on Lead Drug Candidate at Endocrine Society Annual Meeting; Study Shows Advantages of Company's rhIGF-I/rhIGFBP-3 In Treating Growth Disorder
Show 5102550100 per page
  • «
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download

Primary Sidebar

Investor Menu

  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Investor Menu

Footer

Insmed
LinkedIn Twitter

Contact Us

Job Opportunities

  • Our Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Our Patients
    • Disease Areas
      • NTM Lung Disease
      • Bronchiectasis
      • Pulmonary Arterial Hypertension
    • Resources
    • Patient Access
  • Our Science
    • ARIKAYCE®
    • Our Programs
    • Pipeline
    • Clinical Trials
    • Our Research Team
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

© 2022 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy

Culture
Patients
Science
logo
  • Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Patients
    • Disease Areas
      • NTM Lung Disease
      • Bronchiectasis
      • Pulmonary Arterial Hypertension
    • Resources
    • Patient Access
  • Science
    • ARIKAYCE®
    • Our Programs
    • Pipeline
    • Clinical Trials
    • Our Research Team
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs

LinkedIn Twitter

Contact Us Job Opportunities

© 2022 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy